<iframe src="//www.googletagmanager.com/ns.html?id=GTM-K799DP4&l=dataLayer" height="0" width="0" style="display:none;visibility:hidden"></iframe>
NAS:ALNY (USA) Also Trade In: Germany Mexico UK

Alnylam Pharmaceuticals Inc $ 84.78 2.9 (3.54%)

Volume:
865,392
Avg Vol (1m):
678,262
Market Cap $:
9.43 Bil
Enterprise Value $:
7.84 Bil
P/E (TTM):
0.00
P/B:
5.24
Warning! GuruFocus has detected 6 Severe warning signs with ALNY. Click here to check it out.
5D 3M YTD 1Y 5Y 10Y All 1Y (-%)

Financial Strength

5/10
Current Vs Industry Vs History
Cash-To-Debt 5.73
Equity-to-Asset 0.65
Debt-to-Equity 0.19
Debt-to-EBITDA -0.39
N/A
Piotroski F-Score 1
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 3.99
DISTRESS
GREY
SAFE
Beneish M-Score 4.71
Not Manipulator
Manipulator
WACC vs ROIC
ROIC -296.73 %
WACC 14.85 %

Ratios

Current Vs Industry Vs History
PB Ratio 5.24
PS Ratio 88.59
EV-to-EBIT -8.71
N/A
EV-to-EBITDA -8.96
N/A
EV-to-Revenue 77.52
Current Ratio 6.28
Quick Ratio 6.16
Days Inventory 830.06
N/A
Days Sales Outstanding 110.97
Days Payable 2
N/A

Dividend & Buy Back

Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -6

Valuation & Return

Current Vs Industry Vs History
Price-to-Tangible-Book 5.24
Price-to-Median-PS-Value 1.13
Earnings Yield (Greenblatt) % -11.48